Search Results - "MORIDE, Y"

Von Willebrand Disease Epidemiology, Burden of Illness and Management: A Systematic Review by Du, Ping, Bergamasco, Aurore, Moride, Yola, Truong Berthoz, Françoise, Özen, Gülden, Tzivelekis, Spiros

“…Although hereditary von Willebrand disease (VWD) is the most common bleeding disorder, its epidemiology is not well understood. A systematic review (PROSPERO…”
Get full text

Antidepressants and risk of suicide or self-harm in Canadian youth: A study involving common data models in Quebec and British Columbia by Moride, Y, Lynd, T, Ducruet, H, Li, H, Tournier, M, Greenield, B

“…Introduction The use of antidepressants (AD) in children and adolescents has become controversial due to a possible increased risk of suicide, revised evidence…”
Get full text

Effect of treatment gaps in elderly patients with dementia treated with cholinesterase inhibitors by PARIENTE, A, FOURRIER-REGLAT, A, BAZIN, F, DUCRUET, T, DARTIGUES, J. F, DRAGOMIR, A, PERREAULT, S, MOORE, N, MORIDE, Y

“…To determine the effect of treatment gaps on the risk of institutionalization or death among community-dwelling elderly patients treated with cholinesterase…”
Get full text

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis by Henry, David, Lim, Lynette L-Y, Rodriguez, Luis A Garcia, Gutthann, Susanne Perez, Carson, Jeffrey L, Griffin, Marie, Savage, Ruth, Logan, Richard, Moride, Yola, Hawkey, Chris, Hill, Suzanne, Fries, James T

“…Abstract Objective: To compare the relative risks of serious gastrointestinal complications reported with individual non-steroidal anti-inflammatory drugs…”
Get full text

Impact of antidepressants on the risk of suicide in patients with depression in real-life conditions: a decision analysis model by Cougnard, A, Verdoux, H, Grolleau, A, Moride, Y, Begaud, B, Tournier, M

“…The impact of antidepressant drug treatment (ADT) on the risk of suicide is uncertain. The aim of this study was to determine in a real-life setting whether…”
Get more information

P.5.a.003 Increased risk of Alzheimer's disease in benzodiazepine long-term users: a case–control study by Billioti de Gage, S, Moride, Y, Ducruet, T, Kurth, T, Verdoux, H, Tournier, M, Pariente, A, Bégaud, B

Get full text

PND7 Economic Impact of Dementia in the Community-Dwelling Elderly Population of Quebec (Canada) by Beland, S.G, Tannenbaum, C, Ducruet, T, Pariente, A, Moride, Y

Get full text

The risk of cognitive impairment in older community-dwelling women after benzodiazepine use by Lagnaoui, Rajaa, Tournier, Marie, Moride, Yola, Wolfson, Christina, Ducruet, Thierry, Bégaud, Bernard, Moore, Nicholas

“…Long-term benzodiazepine (BZD) use has been associated with cognitive impairment that was reversible [1, 21 or not [3]. Few cohort studies have examined the…”
Get full text

Evaluation of current data sources in Europe for the conduct of real-world studies on lung and renal cell carcinoma: A systematic literature review by Gridchyna, I, Manley Daumont, M, Yousif, A, Hirji, I, Lees, M, Salvo, F, Moride, Y

Get full text

Under-reporting of adverse drug reactions : Estimate based on a spontaneous reporting scheme and a sentinel system by ALVAREZ-REQUEJO, A, CARVAJAL, A, BEGAUD, B, MORIDE, Y, VEGA, T, ARIAS, L. H. M

“…Spontaneous reporting is the most common method used in pharmacovigilance and the best one to generate signals on new or rare adverse drug reactions (ADRs)…”
Get full text

Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study by Depont, F., Fourrier, A., Merlière, Y., Droz, C., Amouretti, M., Bégaud, B., Bénichou, J., Moride, Y., Velo, G. P., Sturkenboom, M., Blin, P., Moore, N.

“…Purpose To describe the characteristics of users of cyclo‐oxygenase (COX)‐2 inhibitors and traditional nonselective non‐steroidal anti‐inflammatory drugs…”
Get full text

Médicaments psychotropes chez l’enfant et l’adolescent by Falissard, B, Verdoux, H, Galéra, C, Moride, Y, Tournier, M

“…L’usage des médicaments psychotropes chez les enfants et les adolescents est à la fois croissant et controversé. La controverse naît de la méconnaissance du…”
Get full text

Under‐reporting of adverse drug reactions in general practice by Moride, Y., Haramburu, F., Requejo, A. A., Bégaud, B.

“…Aims In post‐marketing setting, spontaneous reporting by physicians is a mode of surveillance of adverse effects associated with drug use. The objective of…”
Get full text

P03-317 - Reduced risk of hospitalisation with risperidone long-acting injectable. Results of the french cohort for the general study of schizophrenia (CGS) by Grimaldi-Bensouda, L, Rouillon, F, Astruc, B, Rossignol, M, Benichou, J, Falissard, B, Thibaut, F, Limosin, F, Beaufils, B, Vaiva, G, Verdoux, H, Moride, Y, Abenhaim, L, Rasul, F

“…Introduction Medication non-adherence is a significant risk factor for rehospitalisation in schizophrenia patients. Delayed release formulations like R-LAI may…”
Get full text

Persistency of use of COX-2-specific inhibitors and non-specific non-steroidal anti-inflammatory drugs (NSAIDs) in Quebec by Moride, Y., Ducruet, T., Rochon, S., Lavoie, F.

“…The effectiveness of pharmacological therapies is dependent in part on patient persistency with the prescribed therapeutic regimen. In the case of non-specific…”
Get full text

The CADEUS study: methods and logistics by Depont, F., Fourrier, A., Merlière, Y., Droz, C., Amouretti, M., Bégaud, B., Bénichou, J., Moride, Y., Blin, P., Moore, N.

“…Purpose At the request of the French Health authorities, a study called CADEUS (COX‐2 inhibitors and NSAIDs: description of users) aimed to describe the users…”
Get full text

Non-persistence with antidepressants therapy in the Quebec youth by Tournier, M, Moride, Y, Galbaud du Fort, G, Greenfield, B, Ducruet, T

Get full text

The value of case series in adverse drug reaction assessment by Pariente, Antoine, Chakra, C.N. Abou, Pinet, M., Nkeng, L., Moore, N., Moride, Y.

“…Case studies are recognized as important tools for monitoring drug safety, particularly after the drug is licensed and being used widely. Recently, criteria…”
Get full text

Characterization of Factors Associated with Long-Term Prescription Opioid Use in Support of Risk Mitigation Strategies in the Non-Cancer Population by Pujade, I, Castillon, G, Salvo, F, Moride, Y

“…Introduction: Long-term prescription opioid use in the non-cancer population is highly controversial as it is a known risk factor for opioid-related harms. The…”
Get full text

False‐positives in spontaneous reporting: should we worry about them? by Begaud, B, Moride, Y, Tubert‐Bitter, P, Chaslerie, A, Haramburu, F

“…Spontaneous reporting remains the most used and, undoubtedly, the most cost‐effective approach for the identification of adverse drug reactions (ADRs). Most of…”
Get full text